NCT05621395

To Study the Effect of Investigational Product on Fatigue and Cardiorespiratory Fitness in Healthy Adults.

A Randomized, Double-blind, Placebo-Controlled Study to Explore the Effect of E-OJ-01 on Fatigue and Cardiorespiratory Fitness in Healthy Adults.

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 74 (actual)
• Sponsor: Vedic Lifesciences Pvt. Ltd. · Industry
• Sex: Male
• Age: 30 Years – 60 Years
• Healthy volunteers: Accepted

Summary

E-OJ-01 (Oxyjun®), a proprietary, standardized aqueous extract of TA, has been proven to improve cardiac output and thereby lead to better oxygenation capacity and exercise endurance. This, in turn, averts fatigue and improves physical functioning. Based on the previous studies of E-OJ-01 and the scientific literature available in support of the antioxidant and anti- inflammatory activity of TA bark, in the present study, it is hypothesized that E-OJ-01 will be able to reduce fatigue and improve the cardiorespiratory fitness of the male participants aged between 30 to 60 years.

Conditions

• Fatigue

Interventions

Type	Name	Description
OTHER	E-OJ-01	1 capsule (400 mg) orally to be taken after breakfast daily for 60 days
OTHER	Microcrystalline cellulose	1 capsule (400 mg) orally to be taken after breakfast daily for 60 days

Timeline

• Start date: 2022-11-29
• Primary completion: 2023-09-04
• Completion: 2023-09-04
• First posted: 2022-11-18
• Last updated: 2023-09-08

Locations

4 sites across 1 country: India